• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子与癌症。

Tumour necrosis factor and cancer.

机构信息

Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

出版信息

J Pathol. 2013 Jul;230(3):241-8. doi: 10.1002/path.4188.

DOI:10.1002/path.4188
PMID:23460481
Abstract

Tumour necrosis factor (TNF) was originally described as a circulating factor that can induce haemorrhagic necrosis of tumours. It is now clear that TNF has many different functions in cancer biology. In addition to causing the death of cancer cells, TNF can activate cancer cell survival and proliferation pathways, trigger inflammatory cell infiltration of tumours and promote angiogenesis and tumour cell migration and invasion. These effects can be explained by the diverse cellular responses TNF can initiate through distinct signal transduction pathways, opening the way for more selective targeting of TNF signalling in cancer therapy.

摘要

肿瘤坏死因子(TNF)最初被描述为一种可诱导肿瘤出血坏死的循环因子。现在已经清楚的是,TNF 在癌症生物学中具有许多不同的功能。除了导致癌细胞死亡外,TNF 还可以激活癌细胞的存活和增殖途径,触发肿瘤中炎症细胞的浸润,并促进血管生成和肿瘤细胞的迁移和侵袭。这些作用可以通过 TNF 可以通过不同的信号转导途径启动的多种细胞反应来解释,为在癌症治疗中更有选择性地靶向 TNF 信号通路开辟了道路。

相似文献

1
Tumour necrosis factor and cancer.肿瘤坏死因子与癌症。
J Pathol. 2013 Jul;230(3):241-8. doi: 10.1002/path.4188.
2
The role of TNF superfamily members in T-cell function and diseases.肿瘤坏死因子超家族成员在T细胞功能及疾病中的作用。
Nat Rev Immunol. 2009 Apr;9(4):271-85. doi: 10.1038/nri2526.
3
CD95L/FasL and TRAIL in tumour surveillance and cancer therapy.CD95L/FasL与肿瘤坏死因子相关凋亡诱导配体在肿瘤监测与癌症治疗中的作用
Cancer Treat Res. 2006;130:141-65. doi: 10.1007/0-387-26283-0_7.
4
Role of TWEAK and Fn14 in tumor biology.肿瘤坏死因子样弱凋亡诱导因子(TWEAK)和Fn14在肿瘤生物学中的作用。
Front Biosci. 2007 Jan 1;12:2761-71. doi: 10.2741/2270.
5
Suppression of angiogenesis and tumour progression by combretastatin and derivatives.秋水仙素及其衍生物对血管生成和肿瘤进展的抑制作用。
Cancer Lett. 2017 Sep 10;403:289-295. doi: 10.1016/j.canlet.2017.06.032. Epub 2017 Jul 6.
6
The dual role of tumor necrosis factor (TNF) in cancer biology.肿瘤坏死因子(TNF)在癌症生物学中的双重作用。
Curr Med Chem. 2010;17(29):3337-3352. doi: 10.2174/092986710793176339.
7
TWEAK/Fn14 signaling in tumors.肿瘤中的TWEAK/Fn14信号传导
Tumour Biol. 2017 Jun;39(6):1010428317714624. doi: 10.1177/1010428317714624.
8
Integrin signalling during tumour progression.肿瘤进展过程中的整合素信号传导
Nat Rev Mol Cell Biol. 2004 Oct;5(10):816-26. doi: 10.1038/nrm1490.
9
Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.综述文章:作为癌症治疗靶点的血管生成、新生血管增殖及血管病理生理学
Br J Radiol. 1993 Mar;66(783):181-96. doi: 10.1259/0007-1285-66-783-181.
10
Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth.中性粒细胞介导的肿瘤血管生成:颠覆免疫反应以促进肿瘤生长。
Semin Cancer Biol. 2013 Jun;23(3):149-58. doi: 10.1016/j.semcancer.2013.02.003. Epub 2013 Feb 11.

引用本文的文献

1
Causal relationship between Baff-R expression and normal pressure hydrocephalus: insights from Mendelian randomization analysis.Baff-R表达与正常压力脑积水之间的因果关系:孟德尔随机化分析的见解
BMC Neurol. 2025 Mar 8;25(1):98. doi: 10.1186/s12883-025-04098-4.
2
Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer.用于结肠癌预后、肿瘤免疫微环境评估及候选药物开发的线粒体相关基因特征的综合分析
Sci Rep. 2025 Feb 20;15(1):6173. doi: 10.1038/s41598-024-85035-2.
3
Biochemical evaluation of novel thiazolone derivatives as dual α-glucosidase/α-amylase inhibitors, anti-inflammatory agents.
新型噻唑啉酮衍生物作为双功能α-葡萄糖苷酶/α-淀粉酶抑制剂及抗炎剂的生化评价
Future Med Chem. 2025 Jan;17(2):209-219. doi: 10.1080/17568919.2024.2447225. Epub 2024 Dec 29.
4
DPP4, a potential tumor biomarker, and tumor therapeutic target: review.二肽基肽酶4(DPP4),一种潜在的肿瘤生物标志物和肿瘤治疗靶点:综述
Mol Biol Rep. 2025 Jan 16;52(1):126. doi: 10.1007/s11033-025-10235-6.
5
In situ blockade of TNF-TNFR2 axis via oncolytic adenovirus improves antitumor efficacy in solid tumors.通过溶瘤腺病毒对肿瘤坏死因子-肿瘤坏死因子受体2轴进行原位阻断可提高实体瘤的抗肿瘤疗效。
Mol Ther. 2025 Feb 5;33(2):670-687. doi: 10.1016/j.ymthe.2024.12.011. Epub 2024 Dec 16.
6
Role of Genetic Polymorphisms -238 G>A and -308 G>A, and Serum TNF-α Levels in a Cohort of Mexican Pediatric Neuroblastoma Patients: Preliminary Study.遗传多态性-238 G>A 和-308 G>A 及血清 TNF-α 水平在墨西哥儿科神经母细胞瘤患者队列中的作用:初步研究。
Int J Mol Sci. 2024 Oct 1;25(19):10590. doi: 10.3390/ijms251910590.
7
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and Prognosis.细胞因子与胰腺导管腺癌:探究其与分子亚型和预后的关系。
Int J Mol Sci. 2024 Aug 29;25(17):9368. doi: 10.3390/ijms25179368.
8
Targeting cytokine and chemokine signaling pathways for cancer therapy.针对细胞因子和趋化因子信号通路的癌症治疗。
Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3.
9
NF-κB role on tumor proliferation, migration, invasion and immune escape.NF-κB 在肿瘤增殖、迁移、侵袭和免疫逃逸中的作用。
Cancer Gene Ther. 2024 Nov;31(11):1599-1610. doi: 10.1038/s41417-024-00811-6. Epub 2024 Jul 20.
10
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.以表没食子儿茶素没食子酸酯(EGCG)靶向癌症特征:机制基础和治疗靶点。
Molecules. 2024 Mar 20;29(6):1373. doi: 10.3390/molecules29061373.